What it is & primary uses
A plant alkaloid studied for glucose and lipid metabolism, with meaningful medication considerations.
Main benefits
- May support glucose and lipid markers
Studied protocols
Research doses are grouped by outcome. They describe study designs—not a personal prescription.
1,000–1,500 mg/day, divided
- Study duration
- 8–24+ weeks in many trials
- Interpretation
- A drug-like intervention with broad interaction potential; clinician review is appropriate.
04Food sources & equivalents＋
Can food provide a studied amount?
Berberine is concentrated in roots, rhizomes and bark of medicinal plants rather than common foods.
Highly variable alkaloid content
- How this was estimated
- Plant weight cannot be converted safely without species, plant-part and laboratory alkaloid analysis.
- Important limitation
- These plant materials are pharmacologically active and can interact with medications. They should not be treated as an ordinary food route to a supplement dose.
Food equivalents compare ingredient mass using published composition values. They do not prove equal absorption, formulation, physiological effect, safety or personal need.
Source: Berberine occurrence in medicinal plants ↗05How to take it for absorption & tolerance＋
With food
Berberine trials commonly divide the daily amount around meals to target post-meal glucose exposure and improve tolerance.
- Practical approach
- Use only after checking medications; if used, divide according to the studied product or clinician plan.
- Watch for
- It has drug-like effects and broad interaction potential; pregnancy and breastfeeding are contraindication contexts.
Meal guidance reflects human pharmacokinetic, clinical, official-label or evidence-review sources where available. A food pairing can change absorption or tolerability, but does not make a supplement necessary, effective or safe for every person.
Source: Berberine and glycemic traits meta-analysis ↗06Supplement interaction check＋
An unlisted pair means no established pair-specific interaction was identified in this review—not proof that every dose, product or person is safe.
This is not proof that every dose, product or user context is safe. Medication and condition checks still apply.
07Research notes＋
Moderate evidence for modest glucose and lipid improvements in metabolic disease, but study quality, product quality and drug interactions limit unsupervised use.
Berberine has drug-like effects and a broad interaction profile; clinician review is especially appropriate.
08Scientific references＋
Peer-reviewed human research and formal evidence reviews. Open each source to inspect the complete paper record.
Berberine and cardiovascular risk factors
Dose context: Dose-response models centered near 1 g/day for several outcomes
Modest improvements in lipids, glucose and body-weight markers; trial heterogeneity remains important.
Berberine in type 2 diabetes
Dose context: Multiple divided-dose protocols
Improved HbA1c and fasting/post-meal glucose, particularly as adjunctive therapy; many trials were conducted in China.
Berberine for metabolic-syndrome components
Dose context: Protocols at ≤0.9, 1 and ≥1.5 g/day
Reported modest improvements in triglycerides, fasting glucose, waist circumference and selected secondary markers; more rigorous randomized trials remain necessary.
Recurrent torsades de pointes during multi-supplement use
Dose context: Berberine, dihydroberberine, turmeric and quercetin; individual contributions uncertain
Severe QT prolongation and recurrent arrhythmia occurred with multiple supplements and low magnesium. Recovery followed treatment and supplement withdrawal. This confounded case supports caution, not an estimate of risk or proof that berberine alone caused the event.
09Expert & media references＋
Podcast and practitioner statements are clearly separated from research. They may explain practice or emerging ideas, but do not prove efficacy.
Dose Radar will leave this lane empty rather than invent or infer a professional opinion.